Legend Biotech (LEGN) Gross Profit (2019 - 2025)

Legend Biotech has reported Gross Profit for 7 years, with the latest figure at $242.1 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit rose 75.94% year-over-year to $242.1 million; the trailing twelve-month figure through Dec 2025 stood at $822.9 million (up 71.52% YoY), and the FY2025 full-year result was $823.1 million, up 71.55% from the prior year.
• Gross Profit for Q4 2025 stood at $242.1 million, up from $219.7 million in the prior quarter.
• The five-year high for Gross Profit was $79.5 billion in Q4 2023, with the low at -$13.4 billion in Q1 2021.
• Historically, Gross Profit has averaged $3.4 billion across 5 years, with a median of $60.8 million in 2023.
• Annual changes were most pronounced in 2021 — Gross Profit slumped 268112.76% — and 2023, when it soared 4390174.38%.
• Legend Biotech's Gross Profit stood at -$13.8 million in 2021, then soared by 113.1% to $1.8 million in 2022, then soared by 4390174.38% to $79.5 billion in 2023, then tumbled by 99.83% to $137.6 million in 2024, then jumped by 75.94% to $242.1 million in 2025.
• The last three Gross Profit figures came in at $242.1 million (Q4 2025), $219.7 million (Q3 2025), and $207.0 million (Q2 2025), per Business Quant data.